At-home testing startup LetsGetChecked raised $71 million for its Series C, the company announced Wednesday.
Subscribe to the Crunchbase Daily
The new round, which was co-led by Illumina Ventures and HLM Venture Partners, will be used to increase its supply, manufacturing and testing capabilities for COVID-19, the company said in a statement. The funding will also be used to expand the company’s supply and business operations across the United States and Europe and strengthen partnerships with insurers and employers, according to the company.
“We have been developing our platform for more than five years and have helped hundreds of thousands of individuals by enabling access to high-quality testing and telehealth services in the home, across many health conditions,” CEO Peter Foley said in a statement. “With the onset of COVID-19, we realigned resources with a view to helping with this global pandemic and are currently delivering tens of thousands of tests per day to critical and frontline healthcare workers.”
The company’s COVID-19 tests include an antibody serology test, which produces results within 15 minutes, and a PCR-based test, which requires a swab from the patient that is sent to a lab.
LetsGetChecked also offers other types of testing, including for diabetes, cholesterol, fertility testing and cancer screening.
LetGetChecked is among a growing number of startups that offer at-home testing. Nurx and Everlywell are other prominent players in the space, with both offering STI testing, and Everlywell also offering food sensitivity, thyroid tests and others.
Illustration Credit: Li-Anne Dias